<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 92-year-old man was admitted to the hospital for rehabilitation </plain></SENT>
<SENT sid="1" pm="."><plain>Upper gastrointestinal endoscopy was performed 2 weeks after admission because of <z:hpo ids='HP_0002013'>vomiting</z:hpo> which was found to be due to a Barrett's <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> at the lower esophagus </plain></SENT>
<SENT sid="2" pm="."><plain>We chose chemotherapy with TS-1 at the dose of 50 mg/day in consideration of his age and performance status </plain></SENT>
<SENT sid="3" pm="."><plain>His <z:e sem="disease" ids="C0011168" disease_type="Disease or Syndrome" abbrv="">difficulty in swallowing</z:e> disappeared rapidly </plain></SENT>
<SENT sid="4" pm="."><plain>After 7 days of treatment, grade 3 <z:hpo ids='HP_0002039'>anorexia</z:hpo> appeared, so the dosage of TS-1 was reduced to 25 mg/day </plain></SENT>
<SENT sid="5" pm="."><plain>After the reduction of TS-1, <z:hpo ids='HP_0002039'>anorexia</z:hpo> soon disappeared </plain></SENT>
<SENT sid="6" pm="."><plain>The regimen consisted of TS-1 every 6 weeks as 1 cycle </plain></SENT>
<SENT sid="7" pm="."><plain>After 7 cycles of treatment, upper gastrointestinal endoscopy and upper gastrointestinal series revealed that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> had a completely disappeared </plain></SENT>
<SENT sid="8" pm="."><plain>The effects of chemotherapy were judged as CR </plain></SENT>
<SENT sid="9" pm="."><plain>This case suggests that administration of TS-1 is an effective choice of chemotherapy not only for gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> but also Barrett's <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> </plain></SENT>
</text></document>